New Delhi, Jan. 31 -- Ajanta Pharmaceuticals Q3 Results 2025:Ajanta Pharmaceuticals declared their Q3 results on 30 Jan, 2025, reporting a topline increase of 3.71% year-over-year. The profit surged by 10.88% YoY, amounting to Rs.232.88 crore, while the revenue reached Rs.1146.13 crore. However, compared to the previous quarter, the revenue saw a decline of 3.41%, although profit experienced an increase of 7.58%.

The company's selling, general & administrative expenses rose by 1.61% quarter-over-quarter and saw a significant increase of 14.62% year-over-year, reflecting the rising operational costs.

In terms of operating income, there was a downturn of 5.81% quarter-over-quarter and a slight decrease of 0.88% year-over-year. The earning...